Bill

Bill > AB70


CA AB70

CA AB70
Gene synthesis providers.


summary

Introduced
12/07/2020
In Committee
08/26/2021
Crossed Over
06/01/2021
Passed
09/07/2021
Dead
Vetoed
10/05/2021

Introduced Session

2021-2022 Regular Session

Bill Summary

An act to add Chapter 1.5 (commencing with Section 24200) to Division 20 of the Health and Safety Code, relating to gene synthesis.

AI Summary

This bill aims to improve biosecurity efforts in California by regulating the gene synthesis industry. It requires gene synthesis providers and manufacturers of gene synthesis equipment to either be current members of the International Gene Synthesis Consortium (IGSC) or be verified by the State Department of Public Health as adhering to customer and sequence screening protocols equivalent to or stronger than the IGSC's Harmonized Screening Protocol. The bill also requires entities receiving state resources to purchase gene synthesis products and equipment only from IGSC members or verified providers and manufacturers. The bill imposes penalties for non-compliance and requires the department to develop an appeals process. The bill excludes medical and pharmaceutical research and development from its scope.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (2)

Last Action

Consideration of Governor's veto stricken from file. (on 02/03/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...